A randomized trial of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated malaria among children in western Kenya

BACKGROUND: Artemether-lumefantrine (AL) was adopted as first-line treatment for uncomplicated malaria in Kenya in 2006. Monitoring drug efficacy at regular intervals is essential to prevent unnecessary morbidity and mortality. The efficacy of AL and dihydroartemisinin-piperaquine (DP) were evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Agarwal, Aarti, McMorrow, Meredith, Onyango, Peter, Otieno, Kephas, Odero, Christopher, Williamson, John, Kariuki, Simon, Kachur, Stephen Patrick, Slutsker, Laurence, Desai, Meghna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3722085/
https://www.ncbi.nlm.nih.gov/pubmed/23870627
http://dx.doi.org/10.1186/1475-2875-12-254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3722085/
https://www.ncbi.nlm.nih.gov/pubmed/23870627
http://dx.doi.org/10.1186/1475-2875-12-254

Ejemplares similares